Please confirm you are human (Sign Up for free to never see this)
← Back to Search
Specific And Rapid Induction Of The Proapoptotic Protein Hrk After Growth Factor Withdrawal In Hematopoietic Progenitor Cells.
C. Sanz, A. Benito, N. Inohara, D. Ekhterae, G. Núñez, J. L. Fernández-Luna
Published 2000 · Biology, Medicine
Save to my Library
Download PDFAnalyze on Scholarcy
Hrk is a newly described proapoptotic member of the Bcl-2 family that is mainly expressed in hematopoietic tissues and cultured neurons. In this study we have examined the expression and activity of Hrk in hematopoietic progenitors. To address these issues, we used 3 growth factor-dependent murine hematopoietic cell lines, HCD-57, FDCP-Mix, and FL5.12. The expression of Hrk was undetectable in cells cultured with growth factors, but it was rapidly up-regulated on growth factor withdrawal. In contrast, the expression of Bcl-x(L) decreased and that of proapoptotic Bax, Bad, and Bak was unchanged or down-regulated after removal of growth factors. This pattern of expression correlated with the induction of apoptosis. Hrk was also up-regulated in human cell lines and in bone marrow-derived CD34(+) cells cultured in the absence of growth factors. In addition, the levels of Hrk were up-regulated after treatment with the chemotherapeutic drug etoposide. Expression of prosurvival Bcl-x(L) or Bcl-2 proteins blocked the induction of Hrk. Hrk was induced in FDCP-Mix cells treated with ionomicin in the presence of IL-3, suggesting that cytosolic calcium may regulate the expression of this proapoptotic protein. Furthermore, ectopic expression of Hrk induced cell death of hematopoietic progenitors in the presence of IL-3. Thus, Hrk is specifically and rapidly induced in hematopoietic progenitors after growth factor deprivation or treatment with chemotherapeutic drugs, and this may be sufficient to induce apoptosis in these cells. (Blood. 2000;95:2742-2747)
This paper references
BCL-2 gene family and the regulation of programmed cell death.
S. Korsmeyer (1999)
Ionomycin acts as an ionophore to release TRH-regulated Ca2+ stores from GH4C1 cells.
P. Albert (1986)
Evidence that BCL-2 represses apoptosis by regulating endoplasmic reticulum-associated Ca2+ fluxes.
M. Lam (1994)
Caspases: enemies within.
N. Thornberry (1998)
BID: a novel BH3 domain-only death agonist.
K. Wang (1996)
Blk, a BH3-containing Mouse Protein That Interacts with Bcl-2 and Bcl-xL, Is a Potent Death Agonist*
R. Hegde (1998)
Similar actions of glucocorticoids and calcium on the regulation of apoptosis in S49 cells.
L. A. Caron-Leslie (1991)
Erythropoietin can promote erythroid progenitor survival by repressing apoptosis through Bcl-XL and Bcl-2.
M. Silva (1996)
Massive cell death of immature hematopoietic cells and neurons in Bcl-x-deficient mice
N. Motoyama (1995)
The control of hematopoiesis and leukemia: from basic biology to the clinic.
L. Sachs (1996)
Deregulated Bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines.
G. Núñez (1990)
Haemopoietic colony stimulating factors promote cell survival by suppressing apoptosis
G. Williams (1990)
Functional Activation of Nedd2/ICH-1 (Caspase-2) Is an Early Process in Apoptosis*
N. Harvey (1997)
The Cell Death-promoting Gene DP5, Which Interacts with the BCL2 Family, Is Induced during Neuronal Apoptosis Following Exposure to Amyloid β Protein*
K. Imaizumi (1999)
Interleukin‐3 and Bcl‐2 cooperatively inhibit etoposide‐induced apoptosis in a murine pre‐B cell line
R. Ascaso (1994)
bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death
L. Boise (1993)
The C. elegans Protein EGL-1 Is Required for Programmed Cell Death and Interacts with the Bcl-2–like Protein CED-9
B. Conradt (1998)
Mouse oncostatin M: an immediate early gene induced by multiple cytokines through the JAK‐STAT5 pathway.
A. Yoshimura (1996)
Apoptosis induced by erythroid differentiation of human leukemia cell lines is inhibited by Bcl-XL.
A. Benito (1996)
Intracellularly injected tetanus toxin inhibits exocytosis in bovine adrenal chromaffin cells
R. Penner (1986)
Regulation and function of Bcl-2 during differentiation-induced cell death in HL-60 promyelocytic cells.
A. Benito (1995)
Selective regulation of Bcl-XL by a Jak kinase-dependent pathway is bypassed in murine hematopoietic malignancies.
G. Packham (1998)
Erythropoietin increases c-myc mRNA by a protein kinase C-dependent pathway.
R. Spangler (1991)
Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt.
L. del Peso (1997)
Solution Structure of the Proapoptotic Molecule BID A Structural Basis for Apoptotic Agonists and Antagonists
J. McDonnell (1999)
Bik, a novel death-inducing protein shares a distinct sequence motif with Bcl-2 family proteins and interacts with viral and cellular survival-promoting proteins.
J. Boyd (1995)
harakiri, a novel regulator of cell death, encodes a protein that activates apoptosis and interacts selectively with survival‐promoting proteins Bcl‐2 and Bcl‐XL
N. Inohara (1997)
Glucocorticoids activate a suicide process in thymocytes through an elevation of cytosolic Ca2+ concentration.
D. McConkey (1989)
Prevention of myeloma cell apoptosis by ectopic bcl-2 expression or interleukin 6-mediated up-regulation of bcl-xL.
M. M. Schwarze (1995)
Apoptosis and hematopoiesis in murine fetal liver.
H. Yu (1993)
Mitochondrial cytochrome c release in apoptosis occurs upstream of DEVD‐specific caspase activation and independently of mitochondrial transmembrane depolarization
E. Bossy-Wetzel (1998)
Molecular Cloning of a Novel Polypeptide, DP5, Induced during Programmed Neuronal Death*
K. Imaizumi (1997)
The Bcl-2 protein family: arbiters of cell survival.
J. Adams (1998)
Bad, a heterodimeric partner for Bcl-xL and Bcl-2, displaces bax and promotes cell death
E. Yang (1995)
Control of red cell production: the roles of programmed cell death (apoptosis) and erythropoietin
M. Koury (1990)
The expression of Bcl-x is downregulated during differentiation of human hematopoietic progenitor cells along the granulocyte but not the monocyte/macrophage lineage.
C. Sanz (1997)
This paper is referenced by
Up-regulated expression of genes encoding Hrk and IL-3R beta subunit by TCDD in vivo and in vitro.
J. Park (2002)
SUZ12 Promotes Human Epithelial Ovarian Cancer by Suppressing Apoptosis via Silencing HRK
H. Li (2012)
The role of BH3-only proteins in the immune system
A. Strasser (2005)
Regulation of Apoptosis in Hematopoietic Progenitor Cells: Involvement of Different Signaling Pathways
M. Kraft (2004)
Granulocyte-macrophage colony-stimulating factor (GM-CSF) induces antiapoptotic and proapoptotic signals in acute myeloid leukemia.
S. Faderl (2003)
STRIKING DECREASE IN THE TOTAL PRECURSOR B-CELL COMPARTMENT DURING EARLY CHILDHOOD AS EVIDENCED BY FLOW CYTOMETRY AND GENE EXPRESSION CHANGES
K. Jensen (2010)
Gene Expression and Methylation Pattern in HRK Apoptotic Gene in Myelodysplastic Syndrome
F. Zaker (2016)
Bcl-2 Family Members as Sentinels of Cellular Integrity and Role of Mitochondrial Intermembrane Space Proteins in Apoptotic Cell Death
N. Festjens (2003)
Maternal exposure to polycyclic aromatic hydrocarbons diminishes murine ovarian reserve via induction of Harakiri.
A. Jurisicova (2007)
Small unstable apoptotic protein, an apoptosis-associated protein, suppresses proliferation of myeloid cells.
S. Baker (2003)
BH3-only proteins in cell death initiation, malignant disease and anticancer therapy
V. Labi (2006)
Cytokine control of developmental programs in normal hematopoiesis and leukemia
J. Lotem (2002)
Expression of apoptosis-related genes during human preimplantation embryo development: potential roles for the Harakiri gene product and Caspase-3 in blastomere fragmentation.
A. Jurisicova (2003)
Enhancement of death receptor-mediated apoptosis in multiple myeloma cells
A. Arhoma (2017)
The role of apoptosis in regulating hematopoietic stem cell numbers
J. Domen (2004)
Multiple outcomes for PI3K/Akt/mTOR targeting in non-Hodgkin lymphoma
A. Mueller (2015)
Synergistic silencing by promoter methylation and reduced AP-2α transactivation of the proapoptotic HRK gene confers apoptosis resistance and enhanced tumor growth.
Miao Xu (2013)
Serum suppresses myeloid progenitor apoptosis by regulating iron homeostasis
K. Maclean (2001)
Breast Cancer Cells Can Evade Apoptosis-Mediated Selective Killing by a Novel Small Molecule Inhibitor of Bcl-2
P. Real (2004)
Treating systemic prostate cancer: emerging drug targets and therapies
J. Gulley (2000)
Frequent HRK inactivation associated with low apoptotic index in secondary glioblastomas
M. Nakamura (2005)
Mechanisms of survival and maintenance of Hematopoietic Stem Cells and Multipotent Progenitor Cells
R. Karlsson (2003)
Bcl-2 expression and apoptosis in the regulation of hematopoietic stem cells
C. Orelio (2007)
Erythropoietin Downregulates Bax and DP5 ProApoptotic Gene Expression in Neonatal Hypoxic-Ischemic Brain Injury
A. Kumral (2006)
Regulation of lineage choices during granulopoiesis
M. Buitenhuis (2003)
Differential sensitivity of human papillomavirus type 16+ and type 18+ cervical carcinoma cells to CD95‐mediated apoptosis
A. Aguilar-Lemarroy (2001)
BCL2 Family of Apoptosis-Related Genes: Functions and Clinical Implications in Cancer
Hellinida Thomadaki (2006)
BH3-Only Proteins in Cancer and Apoptosis
F. Ghiotto (2013)
Inactivation of Pleiotropic Regulator 1 reveals p53-dependent Control of Cell Proliferation and Apoptosis by the Pso4-complex
André Kleinridders (2007)
Physical and functional interaction between BH3-only protein Hrk and mitochondrial pore-forming protein p32
J. Sunayama (2004)
Expression of the pro-apoptotic Bcl-2 family member Bim is regulated by the forkhead transcription factor FKHR-L1
P. Dijkers (2000)
Slug, a highly conserved zinc finger transcriptional repressor, protects hematopoietic progenitor cells from radiation-induced apoptosis in vivo.
A. Inoue (2002)See more